Newswise — Baltimore, MD – Sinai Hospital has begun use of a new device that provides timely life-saving treatment for acute stroke patients. The Solitaire FR revascularization device is designed to minimize damage caused by blockage of an artery to the brain by mechanically removing blood clots and restoring blood flow. Recently approved by the FDA for use in patients with acute stroke, the device is especially crucial for those who arrive in the emergency room too late for clot-dissolving drugs to be administered.
“The Solitaire FR represents the next generation in the endovascular treatment of acute strokes,” said John C. Brunson Jr., M.D., director of Interventional Radiology/Neurointerventional Services at Sinai Hospital. “This condition often leads to long-term disability problems and even death if we do not treat it in time. Many acute stroke patients have a window of only a few hours to receive interventional treatment, so every second counts. This device gives us the ability to open up blocked blood vessels more quickly than ever before.”
Brunson recently became the first surgeon in Maryland to use the Solitaire FR to successfully treat a patient with top of the basilar artery stroke, a rare condition that almost always results in death without intervention.
Sinai Hospital is a part of LifeBridge Health, one of the largest, most comprehensive providers of health services in northwest Baltimore. LifeBridge Health also includes Northwest Hospital, Levindale Hebrew Geriatric Center and Hospital, Courtland Gardens Nursing & Rehabilitation Center, and related subsidiaries and affiliates. For more information, visit www.lifebridgehealth.org.